Bovie Medical Corporation Continues to Expand Its Direct Sales Force
Bovie Medical Corporation (NYSE:BVX) , a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has added four Senior Surgical Device Specialists and one Associate Surgical Device Specialist to its direct sales force. They will be responsible for the J-Plasma(R) rollout and growth in their assigned territories.
“Building a dedicated sales force has been a key priority and we are pleased with our continued ability to attract experienced professionals, ” said Robert L. Gershon, Chief Executive Officer. “The new Surgical Device Specialists bring a wealth of expertise in sales and training at leading medical device companies, and their proven track records in product rollouts will benefit J-Plasma(R).”
Ron Steffes joined Bovie as a Senior Surgical Device Specialist, effective October 13, 2014. Most recently, he spent eight years at CryoLife, where he began as a Technical Sales Representative and was promoted to Cardiac Specialist & Field Trainer. Ron’s 14-year medical device career includes sales positions at: the Kendall division of TYCO Healthcare (now Covidien), Aspect Medical, and CardioDynamics.
Christine Dean joined Bovie as a Senior Surgical Device Specialist, effective October 13, 2014. Christine has 12 years of medical device sales experience, most recently with Pursuit Surgical Solutions. Prior to that, Christine held sales positions with Covidien, Intuitive Surgical and Midmark Corporation.
Joe Williams joined Bovie as a Senior Surgical Device Specialist, effective October 13, 2014. Joe has 10 years of medical device sales experience. Most recently, Joe spent eight years at CryoLife, where he began as a Technical Sales Representative and was promoted to Cardiac Specialist & Field Trainer.
Nicole Murphy joined Bovie as a Senior Surgical Device Specialist, effective October 27, 2014. Nicole has over eight years of experience in healthcare. For the last four years, she has been a Sales Consultant with Conmed-Linvatec, representing products in the sports medicine, wound care, and plastic surgery space. Prior to Conmed-Linvatec, Nicole was a Cardiovascular Specialist with SonoSite and a Sales Representative with GlaxoSmithKline and Wraser Pharmaceuticals.
Nick Vukmaravich joined Bovie as an Associate Surgical Device Specialist, effective October 27, 2014. Nick will assist the Senior Surgical Device Specialists in his assigned area, helping to grow revenues by covering cases, and assisting with product evaluations, product demonstrations, and other sales activities. Prior to joining Bovie, Nick was a Sales Associate for Gerson Lehrman Group and a Financial Advisor for Merrill Lynch.
The Senior and Associate Surgical Device Specialists have been awarded stock options to purchase an aggregate of 45,000 shares of Bovie common stock, exercisable at the closing price as of November 6, 2014. The options shall vest and be exercisable in four equal annual installments beginning on the first anniversary of the effective date.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma(R), a patented new plasma-based surgical product for cutting and coagulation. J-Plasma(R) utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal thermal spread, and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie(R), Aaron(R), IDSTM and ICONTM) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s website www.boviemed.com.
Cautionary Statement on Forward-Looking Statements
Certain matters discussed in this release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.
Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this release can be found in the Company’s filings with the Securities and Exchange Commission including the Company’s Reports on Forms 10-K/A and 10-Qs for the year ended December 31, 2013 and the quarters ended March 31, 2014, and June 30, 2014. For forward-looking statements in this release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.
Sorry. No data so far.